Načítá se...
Blockers of Angiotensin Other Than Olmesartan in Patients with Villous Atrophy: A Nationwide Case-Control Study
OBJECTIVE: To examine the association between previous use of non-olmesartan angiotensin receptor blockers (ARBs) or any angiotensin-converting enzyme inhibitors (ACEIs) in patients with small-intestinal villous atrophy (VA) as compared with general population matched controls. PATIENTS AND METHODS:...
Uloženo v:
| Vydáno v: | Mayo Clin Proc |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4469984/ https://ncbi.nlm.nih.gov/pubmed/26046408 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocp.2015.04.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|